Ruxolitinib for preventing relapse of Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis

Authors

Institutions

Publication Details

Journal
Pediatrics International
Published
2025-01-01
DOI
https://doi.org/10.1111/ped.70032
Citations
3
Primary Topic
Autoimmune and Inflammatory Disorders Research
Type
article
Field-Weighted Citation Impact
5.31
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Ruxolitinib for preventing relapse of Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis

Y. Maruyama, Eri Okura, Kenichi Sakamoto, Koichi Hirabayashi et al.
3 citations
Pediatrics International
Autoimmune and Inflammatory Disorders Research
5.31
article

Ruxolitinib for preventing relapse of Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis

Y. Maruyama, Eri Okura, Kenichi Sakamoto, Koichi Hirabayashi, Yozo Nakazawa, Ryu Yanagisawa, Shoji Saito
article en
3 citations

Abstract

No abstract available for this paper.
Pediatrics InternationalVol. 67(1)
Shinshu University (JP), Shinshu University Hospital (JP)
Openalex Percentile: Top 5%
Autoimmune and Inflammatory Disorders Research
5.31
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.